Skip to main navigation Skip to search Skip to main content

Sensorineural hearing loss in children after liver transplantation

  • Ellen S. Deutsch
  • , Victoria Bartling
  • , Brian Lawenda
  • , John Schwegler
  • , Kathleen Falkenstein
  • , Stephen Dunn
  • Temple University
  • Alfred I. duPont Hospital for Children
  • St. Christopher's Hospital for Children
  • Naval Medical Center San Diego

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Objective: To investigate risk factors for sensorineural hearing loss (SNHL) in children after liver transplantation. Design: Retrospective medical record review. Setting: Pediatric tertiary care hospital. Patients: One hundred twenty-five consecutive children who received liver transplants between March 1, 1987, and June 30, 1996. Main Outcome Measures: The presence of SNHL (bone conduction threshold of ≤35 dB of hearing loss in at least i frequency) and the cause of the liver abnormality in all 125 patients. In addition, among the subset of children who had biliary atresia and underwent transplantation before 2 years of age, the total dose (milligrams per kilogram of body weight) of aminoglycoside antibiotic medications (tobramycin sulfate, gentamicin sulfate, and amikacin sulfate) and of intravenous loop diuretic agents (furosemide) was compared between children with and without SNHL. Result: Audiologic evaluations were available for 66 of 125 patients, 15 (12%) of whom have SNHL. Of 5 survivors with the short-bowel syndrome, 4 have severe to profound SNHL. Of 46 children who have biliary atresia and who underwent transplantation before 2 years of age, 8 (17%) have SNHL. Among the 26 evaluable children with biliary atresia undergoing liver transplantation before 2 years of age, logistic regression analysis revealed that the most important risk factor for SNHL was the cumulative dose of amikacin (P = .05). Conclusions: Children receiving liver transplants are at an increased risk for SNHL. Those with the short-bowel syndrome have the greatest prevalence of SNHL. Among the subset of children with biliary atresia receiving liver transplants before 2 years of age, statistical analysis demonstrates a dose- response relationship between the receipt of amikacin and the occurrence of SNHL.

Original languageEnglish
Pages (from-to)529-533
Number of pages5
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume124
Issue number5
DOIs
StatePublished - May 1998
Externally publishedYes

Fingerprint

Dive into the research topics of 'Sensorineural hearing loss in children after liver transplantation'. Together they form a unique fingerprint.

Cite this